​

Xenon Pharmaceuticals Ownership | Who Owns Xenon Pharmaceuticals?

OverviewForecastFinancialsChartTranscripts

Xenon Pharmaceuticals Ownership Summary

Xenon Pharmaceuticals is owned by 45.81% institutional investors, 0.40% insiders, and 53.79% retail investors. Fmr is the largest institutional shareholder, holding 9.66% of XENE shares. American Funds SMALLCAP World A is the top mutual fund, with 6.33% of its assets in Xenon Pharmaceuticals shares.

XENE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXenon Pharmaceuticals45.81%0.40%53.79%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr7.53M9.66%$294.99M
Avoro capital advisors5.67M7.27%$222.13M
Driehaus capital management4.42M5.70%$172.32M
Wellington management group llp3.78M4.85%$148.08M
Braidwell lp2.91M3.74%$114.23M
Janus henderson group2.87M3.68%$112.43M
Commodore capital lp2.74M3.52%$107.41M
Capital investors2.55M3.27%$99.85M
Polar capital2.54M3.27%$98.88M
Capital world investors2.29M2.94%$89.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp2.74M7.87%$107.41M
Affinity asset advisors1.16M6.10%$45.52M
Saturn v capital management322.47K4.95%$12.64M
First turn management684.99K4.81%$26.85M
Great point partners245.27K4.53%$9.61M
First light asset management1.16M4.35%$45.49M
Ally bridge group (ny)129.29K4.35%$5.07M
Stempoint capital lp375.85K3.68%$14.73M
Nan fung group106.68K3.58%$4.18M
Braidwell lp2.91M3.39%$114.23M

Top Buyers

HolderShares% AssetsChange
Fmr7.53M0.02%607.61K
Westfield capital management co lp1.16M0.20%487.59K
Jpmorgan chase1.36M0.00%380.11K
Stempoint capital lp375.85K3.68%375.85K
First turn management684.99K4.81%359.77K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---2.04M
Capital world investors2.29M0.01%-387.00K
Point72 asset management---383.29K
Logos global management lp---375.00K
Avidity partners management lp474.00K1.82%-344.00K

New Positions

HolderShares% AssetsChangeValue
Stempoint capital lp375.85K3.68%375.85K$14.73M
Saturn v capital management322.47K4.95%322.47K$12.64M
Great point partners245.27K4.53%245.27K$9.61M
Deep track capital, lp169.13K0.25%169.13K$6.63M
Eversept partners, lp155.54K0.54%155.54K$6.10M

Sold Out

HolderChange
Dinuzzo private wealth-2.00
Srs capital advisors-3.00
Sjs investment consulting-5.00
Jfs wealth advisors-8.00
Park place capital-18.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024117-43.75%35,698,172-52.33%450.50%51-43.33%38-38.71%
Sep 30, 2024207-4.17%74,878,3241.04%961.05%91-5.21%61-15.28%
Jun 30, 2024216-3.57%74,109,2450.93%951.07%96-15.79%725.88%
Mar 31, 20242241.36%73,423,1981.98%940.89%114-16.79%6830.77%
Dec 31, 202322113.33%72,000,39717.42%1021.19%13742.71%526.12%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
American Funds SMALLCAP World A4.83M6.33%-420.69K
Vanguard Health Care Inv2.54M3.33%-
Polar Capital Biotech S Inc1.75M2.29%-
Fidelity Select Health Care1.25M1.63%-
Strategic Advisers Fidelity US TtlStk1.07M1.40%241.18K
Fidelity Advisor Health Care I780.00K1.02%-
Fidelity Advisor Biotechnology I710.76K0.93%-
Pictet Biotech658.54K0.87%658.54K
Polar Capital Healthcare Opports Inc652.16K0.85%-
Pictet-Biotech P USD635.94K0.83%-10.25K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 27, 2025MORTIMER IAN PRESIDENT & CEOSell$47.19K
Jan 23, 2025MORTIMER IAN PRESIDENT & CEOSell$649.98K
Jan 27, 2025MORTIMER IAN PRESIDENT & CEOSell$613.62K
Jan 24, 2025MORTIMER IAN PRESIDENT & CEOSell$903.21K
Dec 18, 2024AULIN SHERRY Chief Financial OfficerSell$296.81K

Insider Transactions Trends

DateBuySell
2025 Q1-4
2024 Q4-4
2024 Q2--
2024 Q1-7
2023 Q4-5

XENE Ownership FAQ

Who Owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals shareholders are primarily institutional investors at 45.81%, followed by 0.40% insiders and 53.79% retail investors. The average institutional ownership in Xenon Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Xenon Pharmaceuticals falls below.

Who owns the most shares of Xenon Pharmaceuticals?

Xenon Pharmaceuticals’s largest shareholders are Fmr (7.53M shares, 9.66%), Avoro capital advisors (5.67M shares, 7.27%), and Driehaus capital management (4.42M shares, 5.70%). Together, they hold 22.62% of Xenon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Xenon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Xenon Pharmaceuticals.

Who is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Xenon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.87% of its assets in 2.74M Xenon Pharmaceuticals shares, valued at 107.41M$.

Who is the top mutual fund holder of Xenon Pharmaceuticals shares?

American Funds SMALLCAP World A is the top mutual fund holder of Xenon Pharmaceuticals shares, with 6.33% of its total shares outstanding invested in 4.83M Xenon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools